Results 201 to 210 of about 7,663 (215)

Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial

Lancet Diabetes and Endocrinology,the, 2018
George J Kahaly, Jochem König, Anja Eckstein   +2 more
exaly  

Graves' Orbitopathy

2010
openaire   +1 more source

Quality of life and neuropsychiatric disorders in patients with Graves' Orbitopathy: Current concepts

Autoimmunity Reviews, 2018
Alice Bruscolini, Marta Sacchetti, Maurizio La Cava   +2 more
exaly  

Graves' Orbitopathy

2014
openaire   +1 more source

Oxidative stress and Graves’ orbitopathy

Archivos de la Sociedad Española de Oftalmología (English Edition), 2012
I, Genol Saavedra, N, Toledano Fernández, A, Nogueira Goriba   +2 more
openaire   +2 more sources

High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study

Thyroid, 2018
maria antonietta profilo, Marco Nardi, Paolo Vitti   +2 more
exaly  

Graves orbitopathy - asymmetric

2022
openaire   +1 more source

Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic Review

Ophthalmology and Therapy, 2019
Fatemeh Rajaii, Amanda D Henderson
exaly  

Graves Orbitopathy

Endocrine Abstracts, 2019
openaire   +1 more source

Graves' Orbitopathy

2016
openaire   +1 more source